Transfusion of Blood and Blood Products
The transfusion of blood and blood products should be performed only as a last resort in patients with chronic anemia or acute bleeding. Prevention and early diagnosis of anemia or bleeding can help minimize the need for transfusion of blood and blood products. For a patient with chronic anemia, the use of iron and vitamin supplements is often sufficient to raise the hemoglobin level enough so a transfusion isn’t required.
If the patient is experiencing acute bleeding, the first line of treatment should be IV fluids, such as crystalloids or colloids, to help increase the circulating volume. If the patient requires a blood transfusion, it’s very important to make sure that the right patient is receiving the right blood or blood product. If a patient receives the wrong blood or blood product, it could cause a serious reaction and possibly death. Before administering blood or a blood product, you should be familiar with the different types of blood and blood products (See Transfusing blood and selected blood products.)
Equipment
Blood or blood component administration set as appropriate ▪ IV pole ▪ gloves ▪ blood or blood product ▪ 10-mL syringe ▪ 250 mL of normal saline solution ▪ IV catheter equipment, if necessary (should include 14G to 24G catheter).3
Straight line and Y-type blood administration sets (Y-type is most commonly used) contain a standard blood filter designed to eliminate blood clots and cellular debris that occur during blood storage. A standard blood filter will trap particles that are 170 microns or larger. There are times, however, when a specialized blood filter may be required. (See Specialized blood filters, page 745.)
Preparation of Equipment
Avoid obtaining the blood or blood product until you’re ready to begin the transfusion. The transfusion should begin within 30 minutes of obtaining the blood or blood product to decrease the risk of bacterial growth.3 Prepare the equipment when you’re ready to start the infusion.
Implementation
Make sure that a written order is in the patient’s medical record. Confirm that the order and the medical record are labeled with the patient’s name and assigned identification number.3,5
Verify that the patient or his legally authorized representative has signed an informed consent form before transfusion therapy is initiated and that the form is in the patient’s medical record according to your facility’s policy.6,7 Some facilities don’t require consent for blood components such as albumin; make sure you’re familiar with your facility’s policy.
Ensure that the indication for the transfusion is documented in the patient’s medical record.
Gather the equipment.
Confirm the patient’s identity using at least two patient identifiers according to your facility’s policy.11
Explain the procedure to the patient.
If the patient doesn’t have an IV catheter in place, insert one. Use a catheter that’s 24G or larger in diameter.3 The selection of the catheter size depends on the location, size, and integrity of the patient’s veins. A smaller catheter usually requires a slower rate of transfusion. (See “IV catheter insertion and removal,” page 421.)
If an existing IV catheter is in place, verify it’s an appropriate size and that it’s patent by using a 10-mL syringe to aspirate for blood return.12 Central venous access devices also may be used for transfusion therapy.
Transfusing Blood and Selected Blood Products
Blood component | Indications | Compatibility | Nursing considerations |
---|---|---|---|
Packed red blood cells (RBCs) Same RBC mass as whole blood but with 80% of the plasma removed |
|
|
|
Leukocyte-poor RBCs Same as packed RBCs with about 70% of the leukocytes removed |
|
|
|
Platelets Platelet sediment from RBCs or plasma platelets |
|
|
|
Fresh frozen plasma (FFP) Uncoagulated plasma separated from RBCs and rich in coagulation factors V, VIII, and IX |
|
|
|
Albumin 5% (buffered saline); albumin 25% (salt-poor) A small plasma protein prepared by fractionating pooled plasma |
|
|
|
Factor VIII concentrate (antihemophilic factor) Cold insoluble portion of plasma recovered from FFP |
|
|
|
Cryoprecipitate Insoluble plasma portion of FFP containing fibrinogen, factor VIIIc, factor VIIvWF, factor XIII, and fibronectin |
|
|
|
Record the patient’s baseline vital signs.
Obtain the blood or blood product from the blood bank. Check the expiration date on the blood bag, and observe for abnormal color, red blood cell (RBC) clumping, gas bubbles, and extraneous material.2,3 Return outdated or abnormal blood to the blood bank.Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree